Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Amortization of Deferred Charges: 2020-2024

Historic Amortization of Deferred Charges for P3 Health Partners (PIII) over the last 4 years, with FY2024 value amounting to $87000.0.

  • P3 Health Partners' Amortization of Deferred Charges rose 5689.46% to $19.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.1 million, marking a year-over-year increase of 6591.71%. This contributed to the annual value of $87000.0 for FY2024, which is 8156.78% down from last year.
  • According to the latest figures from FY2024, P3 Health Partners' Amortization of Deferred Charges is $87000.0, which was down 8156.78% from $472000.0 recorded in FY2023.
  • In the past 5 years, P3 Health Partners' Amortization of Deferred Charges registered a high of $1.8 million during FY2021, and its lowest value of $80237.0 during FY2020.
  • For the 4-year period, P3 Health Partners' Amortization of Deferred Charges averaged around $609309.2, with its median value being $279500.0 (2023).
  • The largest annual percentage gain for P3 Health Partners' Amortization of Deferred Charges in the last 5 years was 8156.78% (2024), contrasted with its biggest fall of 8156.78% (2024).
  • Annual analysis of 4 years shows P3 Health Partners' Amortization of Deferred Charges stood at $80237.0 in 2020, then soared by 2140.86% to $1.8 million in 2021, then crashed by 73.75% to $472000.0 in 2023, then crashed by 81.57% to $87000.0 in 2024.
  • Its Amortization of Deferred Charges was $87000.0 in FY2024, compared to $472000.0 in FY2023 and $1.8 million in FY2021.